123 related articles for article (PubMed ID: 38354926)
1. Autoinhibition of suicidal capsid protease from O'nyong'nyong virus.
Chykunova Y; Plewka J; Wilk P; Torzyk K; Sienczyk M; Dubin G; Pyrc K
Int J Biol Macromol; 2024 Mar; 262(Pt 2):130136. PubMed ID: 38354926
[TBL] [Abstract][Full Text] [Related]
2. trans-Protease activity and structural insights into the active form of the alphavirus capsid protease.
Aggarwal M; Dhindwal S; Kumar P; Kuhn RJ; Tomar S
J Virol; 2014 Nov; 88(21):12242-53. PubMed ID: 25100849
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity and virulence of O'nyong-nyong virus: A less studied
Tong Jia Ming S; Tan Yi Jun K; Carissimo G
Virulence; 2024 Dec; 15(1):2355201. PubMed ID: 38797948
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.
Chan YH; Teo TH; Torres-Ruesta A; Hartimath SV; Chee RS; Khanapur S; Yong FF; Ramasamy B; Cheng P; Rajarethinam R; Robins EG; Goggi JL; Lum FM; Carissimo G; Rénia L; Ng LFP
Front Immunol; 2020; 11():894. PubMed ID: 32477364
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein.
Aggarwal M; Kaur R; Saha A; Mudgal R; Yadav R; Dash PK; Parida M; Kumar P; Tomar S
Antiviral Res; 2017 Oct; 146():102-111. PubMed ID: 28842264
[TBL] [Abstract][Full Text] [Related]
6. O'nyong'nyong virus: next arbovirus in Latin America?
Rios-González CM
J Infect Public Health; 2018; 11(1):139. PubMed ID: 28215916
[No Abstract] [Full Text] [Related]
7. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus.
Pezzi L; LaBeaud AD; Reusken CB; Drexler JF; Vasilakis N; Diallo M; Simon F; Jaenisch T; Gallian P; Sall A; Failloux AB; Weaver SC; de Lamballerie X;
Antiviral Res; 2019 Dec; 172():104611. PubMed ID: 31545982
[TBL] [Abstract][Full Text] [Related]
8. Mxra8 is a receptor for multiple arthritogenic alphaviruses.
Zhang R; Kim AS; Fox JM; Nair S; Basore K; Klimstra WB; Rimkunas R; Fong RH; Lin H; Poddar S; Crowe JE; Doranz BJ; Fremont DH; Diamond MS
Nature; 2018 May; 557(7706):570-574. PubMed ID: 29769725
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of aura virus capsid protease and its complex with dioxane: new insights into capsid-glycoprotein molecular contacts.
Aggarwal M; Tapas S; Preeti ; Siwach A; Kumar P; Kuhn RJ; Tomar S
PLoS One; 2012; 7(12):e51288. PubMed ID: 23251484
[TBL] [Abstract][Full Text] [Related]
10. Structure-function insights into chikungunya virus capsid protein: Small molecules targeting capsid hydrophobic pocket.
Sharma R; Kesari P; Kumar P; Tomar S
Virology; 2018 Feb; 515():223-234. PubMed ID: 29306785
[TBL] [Abstract][Full Text] [Related]
11. High rates of o'nyong nyong and Chikungunya virus transmission in coastal Kenya.
LaBeaud AD; Banda T; Brichard J; Muchiri EM; Mungai PL; Mutuku FM; Borland E; Gildengorin G; Pfeil S; Teng CY; Long K; Heise M; Powers AM; Kitron U; King CH
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003436. PubMed ID: 25658762
[TBL] [Abstract][Full Text] [Related]
12. Vector competence of Anopheles stephensi for O'nyong-nyong virus: a risk for global virus spread.
Mutsaers M; Engdahl CS; Wilkman L; Ahlm C; Evander M; Lwande OW
Parasit Vectors; 2023 Apr; 16(1):133. PubMed ID: 37069603
[TBL] [Abstract][Full Text] [Related]
13. O'nyong-nyong fever: a neglected mosquito-borne viral disease.
Rezza G; Chen R; Weaver SC
Pathog Glob Health; 2017 Sep; 111(6):271-275. PubMed ID: 28829253
[TBL] [Abstract][Full Text] [Related]
14. O'nyong nyong virus molecular determinants of unique vector specificity reside in non-structural protein 3.
Saxton-Shaw KD; Ledermann JP; Borland EM; Stovall JL; Mossel EC; Singh AJ; Wilusz J; Powers AM
PLoS Negl Trop Dis; 2013; 7(1):e1931. PubMed ID: 23359824
[TBL] [Abstract][Full Text] [Related]
15. FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
Ng WH; Liu X; Ling ZL; Santos CNO; Magalhães LS; Kueh AJ; Herold MJ; Taylor A; Freitas JR; Koit S; Wang S; Lloyd AR; Teixeira MM; Merits A; Almeida RP; King NJC; Mahalingam S
Nat Commun; 2023 Oct; 14(1):6605. PubMed ID: 37884534
[TBL] [Abstract][Full Text] [Related]
16. Development of a Real-Time Reverse Transcription Polymerase Chain Reaction for O'nyong-nyong Virus and Evaluation with Clinical and Mosquito Specimens from Kenya.
Waggoner J; Heath CJ; Ndenga B; Mutuku F; Sahoo MK; Mohamed-Hadley A; Vulule J; Mukoko D; Desiree LaBeaud A; Pinsky BA
Am J Trop Med Hyg; 2017 Jul; 97(1):121-124. PubMed ID: 28719301
[TBL] [Abstract][Full Text] [Related]
17. No Evidence of O'nyong-nyong Viremia among Children with Febrile Illness in Kenya (2015-2018).
Shah MM; Ndenga BA; Mutuku FM; Okuta V; Ronga CO; Chebii PK; Maina P; Jembe Z; Sahoo MK; Huang C; Weber J; Pinsky BA; LaBeaud AD
Am J Trop Med Hyg; 2021 Feb; 104(4):1435-1437. PubMed ID: 33617476
[TBL] [Abstract][Full Text] [Related]
18. Multiple capsid protein binding sites mediate selective packaging of the alphavirus genomic RNA.
Brown RS; Anastasakis DG; Hafner M; Kielian M
Nat Commun; 2020 Sep; 11(1):4693. PubMed ID: 32943634
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Analyses of the Multifocal Effects of Natural Alkaloids Berberine, Matrine, and Tabersonine against the O'nyong-nyong Arthritogenic Alphavirus Infection and Inflammation.
Sandenon Seteyen AL; Guiraud P; Gasque P; Girard-Valenciennes E; Sélambarom J
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631040
[TBL] [Abstract][Full Text] [Related]
20. Specific Recognition of a Stem-Loop RNA Structure by the Alphavirus Capsid Protein.
Brown RS; Kim L; Kielian M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
